Animal Efficacy Testing

Drug Discovery

DormaTarg provides both conventional flank xenograft models and orthotopic xenografts of human tumors in nude mice as well as novel chicken embryo tumor xenograft systems for systemic angiogenesis and tumor growth testing. DormaTarg can also provide animal model testing for non-cancer diseases.

Services

News

  • Nov. 1, 2011 - DormaTarg awarded SBIR Phase II Grant for $2MM

  • Dec. 3, 2010 - DormaTarg awarded OCAST R&D Intern Partnerships Grant for $47,000

  • Dec. 2, 2010 - Dr. Ihnat awarded OARS Grant for $91,570